Anne Edelstein

Executive Director
13 years industry experience

Biography

Anne Edelstein is an investor for Counterpoint Global. She joined Morgan Stanley in 2018 and has 13 years of investment experience. Prior to joining the firm, she was a Vice President and Equity Research Analyst at Bank of America Merrill Lynch (BAML) following life science tools and diagnostics. She previously covered semiconductors and specialty pharmaceuticals, also for BAML. Anne earned a B.A. in neuroscience at Hamilton College.

Anne is a member of
Counterpoint Global

View Team

Strategies

Strategy Name	Description
Vitality	Invests primarily in companies principally engaged in the discovery, development, production, or distribution of products or services related to advances in healthcare.

Vitality

Invests primarily in companies principally engaged in the discovery, development, production, or distribution of products or services related to advances in healthcare.